Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care

Health Technology Assessment

Volumn 13, Issue 32, 2009, Pages

  Mant, J ^a,e   Doust, J ^b   Roalfe, A ^a   Barton, P ^a   Cowie, M R ^c   Glasziou, P ^d   Mant, D ^d   McManus, R J ^a   Holder, R ^a   Deeks, J ^a   Fletcher, K ^a   Qume, M ^a   Sohanpal, S ^a   Sanders, S ^b   Hobbs, F D R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BOND UNIVERSITY   (Australia)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LISINOPRIL; LOSARTAN;

ANAMNESIS; ANKLE EDEMA; CARDIOMEGALY; CARDIOVASCULAR RISK; CENTRAL VENOUS PRESSURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CINAHL; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DECISION TREE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRUG COST; DYSPNEA; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; EDEMA; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; HEALTH CARE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART SOUND; HEPATOMEGALY; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MEDLINE; PAROXYSMAL DYSPNEA; PATIENT CODING; PREDICTION; PREVALENCE; PRIMARY MEDICAL CARE; PROGNOSIS; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; SYMPTOM; SYSTEMATIC REVIEW; TACHYCARDIA; THORAX RADIOGRAPHY; UNITED KINGDOM;

EID: 70349459647     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta13320     Document Type: Review

References (197)

1. Gillum RF. Epidemiology of heart failure in the United States. Am Heart J 1993;126:1042-1047 (Pubitemid 23291405)
2. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994;13(Suppl. 4):S107-12.
3. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-1435
4. Hobbs FDR, Roalfe AK, Davis RC, Davies MK, Hare R. Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J 2007;28:1128-1134 (Pubitemid 47343888)
5. McKee PA. Castelli WP, McNamara PM, Kannell WB. The natural history of heart failure: the Framingham Study. N Engl J Med 1971;285:1441-1446
6. Ho KKL, Pinsky JL, Kannel WB. The epidemiology of heart failure: the Framingham study. Am J Cardiol 1993;22(Suppl. A):6A-13A.
7. Marantz PR, Tobin JN, Wassertheil-Smoller S, Steingart RM, Wexler JP, Budner N, et al. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1988;77:607-612 (Pubitemid 18073352)
8. Clarke KW, Gray D, Hampton JR. How common is heart failure? Evidence from PACT (prescribing analysis and cost) data in Nottingham. J Public Health Med 1995;17:459-464 (Pubitemid 26027094)
9. Parameshwar J, Shackell MM, Richardson A, Poole-Wilson PA, Sutton GC. Prevalence of heart failure in three general practices in North West London. Br J Gen Pract 1992;42:287-289
10. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJV, et al. Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997;350:829-833 (Pubitemid 27404343)
11. Morgan S, Smith H, Simpson I, Liddiard GS, Raphael H, Pickering RM, et al. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey. BMJ 1999;318:368-372 (Pubitemid 29192086)
12. Davies MK, Hobbs FDR, Davis RC, Kenkre JE, Roalfe AK, Hare R, et al. Prevalence of left ventricular systolic dysfunction and heart failure in the general population: main findings from the ECHOES (Echocardiographic Heart of England Screening) Study. Lancet 2001;358:439-445 (Pubitemid 32769849)
13. Cowie MR, Wood DA, Coats A, Thompson SG, Poole-Wilson PA, Suresh V, et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 1999;20:421-428 (Pubitemid 29116538)
14. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
15. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-533 (Pubitemid 27085732)
16. RALES Investigators. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol 1996;78:902-907
17. Domanski MJ. Beta-Blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol 2000;35(Suppl. A):202A.
18. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-115 (Pubitemid 23195439)
19. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-306
20. McDonagh T,A, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001;86:21-26 (Pubitemid 32977774)
21. Cleland JGF, Gemmell, I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail 1999;1:229-241
22. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJV. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-322
23. Swedberg K, Cleland J, Dargie H, Drexler H, Tollath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-1210
24. Hobbs FDR, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002;23:1867-1876 (Pubitemid 35398056)
25. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. JAMA 1989;262:907-913
26. Cline CM, Willenheimer RB, Erhardt LR, Wiklund I, Israelsonn BY. Health related quality of life in elderly patients with heart failure. Scand Cardiovasc J 1999;33:278-285 (Pubitemid 29465528)
27. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol 1999;84:348-350 (Pubitemid 29365139)
28. Murberg TA, Bru E, Svebak S, Tveteras R, Aarsland T. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-years follow-up study. Int J Psychiatry Med 1999;29:311-326 (Pubitemid 30036534)
29. Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-63.
30. Sutton GC. Epidemiological aspects of heart failure. Am Heart J 1990;120:1538-1540
31. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalisation for heart failure in Scodand 1980-1990. Eur Heart J 1993;14:1158-1162
32. Eriksson H. Heart failure: a growing public health problem. J Intern Med 1995;237:135-141
33. Bundkirchen A, Schwinger RHG, et al. Epidemiology and economic burden of chronic heart failure. Eur Heart J 2004;6(Suppl. D):D57-60.
34. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-259 (Pubitemid 44079340)
35. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-1456
36. American College of Cardiology/American Heart Association. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart failure). Circulation 1995;92:2764-2784
37. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, et al. for the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-677
38. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II. Lancet 1999;353:9-13.
39. Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Beta-blockers in heart failure: meta-analysis of randomized trials. Circulation 1998;98:1184-1191
40. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
41. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691
42. Willenheimer R, Erhardt L, Cline C, Rydberg E, Israelsson B. Exercise training in heart failure improves quality of life and exercise capacity. Eur Heart J 1998;19:774-781 (Pubitemid 28227162)
43. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-1195 (Pubitemid 26392440)
44. Pitt B, White H, Nicolau J, Martinez F, Gheorghiade M, Aschermann M, et al. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol. 2005;46:425-431 (Pubitemid 41040281)
45. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-551 (Pubitemid 39025171)
46. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, Michelson EL, et al., for the CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003;326:759-766
47. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994;71:584-587 (Pubitemid 24224829)
48. Hobbs FDR, Jones MI, Allan TS, Wilson S, Jones MI, Tobias R. European survey of primary care physician perceptions and practice in heart failure diagnosis and management (Euro-HF study). Eur Heart J 2000;21:1877-1887.
49. Nicol ED, Fittall B, Roughton M, Cleland J, Dargie H, Cowie MR. NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland. Heart 2008;94:172-177
50. National Collaborating Centre for Chronic Conditions. Chronic heart failure: national clinical guideline for diagnosis and management in primary and secondary care. Full version of NICE Guideline No. 5. London: Royal College of Physicians; 2003.
51. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-e235.
52. Hobbs FDR, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002;324:1498-1503 (Pubitemid 34666621)
53. Healthcare Commission. Getting to the heart of it: coronary heart disease in England: a review of progress towards the national standards. London: Commission for Health Care Audit and Inspection; 2005.
54. Cleland JGF, Cohen-Solal A, Cosin Aguilar J, Dietz R, Eastaugh J, Follath F, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2003;360;1631-1641
55. Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw TRD, et al. Value of an electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996;312:222. (Pubitemid 26031435)
56. The NETWORK Investigators. Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. Eur Heart J 1998;19:481-489
57. Badgett RG, Mulrow CD, Otto PM, Ramirez G. How well can the chest radiograph diagnose left ventricular dysfunction? J Gen Intern Med 1996;11:625-634
58. Alam M, Rosenhamer G, Hogland C. Compatibility of echocardiography and chest x-ray following myocardial infarction. J Intern Med 1989;226:771-773 (Pubitemid 19226066)
59. Badgett RG, Lucey LR, Murlow CD. Can clinical examination diagnose left-sided heart failure in adults. JAMA 1997;277:1712-1719
60. Weeldon NM, McDonald TM, Fluker CJ, McKendrick AD, McDevitt DG, Struthers AD. Echocardiography in chronic heart failure in the community. Q J Med 1993;86:17-20.
61. Davis RC, Hobbs FDR, Roalfe AK, Hare R, Kenkre JE, Hare R, et al. Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study. BMJ 2002;325:1156-1158 (Pubitemid 35398713)
62. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-321
63. Anonymous. Failure to treat heart failure (editorial). Lancet 1992;339:278-279
64. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994;72:584-587 (Pubitemid 24224829)
65. Troughton R, Frampton C, Yandle T, Espine E, Nicholls M, Richards A. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-1130 (Pubitemid 30172933)
66. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007;49:1733-1739 (Pubitemid 46589928)
67. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnoea. N Engl J Med 2004;350:647-654 (Pubitemid 38364623)
68. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004;164:1978-1984 (Pubitemid 39390553)
69. Doust JA, Saunders S, Pirozzo S, Francis D, Pietrzak E, Del Mar C, et al.. The diagnosis and recognition of congestive cardiac failure. Melbourne, Australia: Centre for Evidence Based Practice, University of Queensland, National Institute of Clinical Studies; 2002.
70. Craig J, Bradbury I, Cummins E, Downie S, Foster L, Stout A. The use of B-type natriuretic peptides in the investigation of patients with suspected heart failure. Edinburgh: Health Technology Assessment Report 6, NHS Quality Improvement Scotland; May 2005.
71. Khunti K, Squire I, Abrams KR, Sutton AJ. Accuracy of a 12-lead electrocardiogram in screening patients with suspected heart failure for open access echocardiography: a systematic review and meta-analysis. Eur J Heart Fail 2004;6:571-576 (Pubitemid 39070511)
72. Mosterd A, Deckers JW, Hoes AW, Nederpel A, Smeets A, Linker DT, et al. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 1997;13:491-502. (Pubitemid 27306166)
73. Mant J, Fitzmaurice D, Hobbs FDR, Jowett S, Murray ET, Holder R, et al. Accuracy of diagnosing atrial fibrillation on an electrocardiogram (ECG) by primary care practitioners and interpretative diagnostic software - analysis of data from the Screening for Atrial Fibrillation in the Elderly (SAFE) trial. BMJ 2007. Published online 29 June 2007.
74. Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al. Clinical applications of B-type natriuretic peptide testing. Eur Heart J 2003;24:1710-1718 (Pubitemid 37236859)
75. Doust JA, Pettrzak E, Sanders S, Glasziou PP. Identifying studies for systematic reviews of diagnostic tests was difficult due to the poor sensitivity and precision of methodologic filters and the lack of information in the abstract. J Clin Epidemiol 2005;58:444-9.
76. Whiting P, Rutjes AWS, Dinnes J, Reitsma JB, Bossuyt PMM, Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 2004;8(25):iii, 1-234. (Pubitemid 38967660)
77. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007;8:239-51. (Pubitemid 46569586)
78. Macaskill, P. Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis. J Clin Epidemiol 2004;57:925-932 (Pubitemid 39422529)
79. Fonseca C, Sarmento PM, Minez A, Goncalves E, Covas R, Dias AR, et al. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Rev Port Cardiol 2004;23:979-991 (Pubitemid 39277301)
80. Alehagen U, Lindstedt G, Eriksson H, Dahlstrom U. Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care. Clin Chem 2003;49:1337-1346 (Pubitemid 36900620)
81. Galasko GI, Lahiri A, Barnes SC. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J 2005;26:2269-76.
82. Hobbs FDR, Davis RC, Roalfe AK, Hare R, Davies MK. Reliability of N-terminal pro-BNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations. Heart 2004;90:866-870 (Pubitemid 39005929)
83. Rutten FH, Moons KG, Cramer MJ, Grobbee DE, Zuithoff NP, Lammers JW, et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005;331:1379.
84. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-1353
85. Fox KF, Cowie MR, Wood DA, Coats AJ, Poole-Wilson PA, Sutton GC. A rapid access heart failure clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community. Eur J Heart Fail 2000;2:423-429
86. Lim TK, Senior R. Noninvasive modalities for the assessment of left ventricular function: all are equal but some are more equal than others. J Nucl Cardiol 2006;13:445-449 (Pubitemid 44204154)
87. Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 2003;42:1793-1800 (Pubitemid 37433660)
88. Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail 2005;7:537-541 (Pubitemid 40732984)
89. Jose JV Gupta SN, Selvakumar D. Utility of N-terminal pro-brain natriuretic peptide for the diagnosis of heart failure. Indian Heart J 2003;55:35-39 (Pubitemid 36582680)
90. Knudsen CW, Omland T, Clopton P, Westheim A, Abraham WT, Storrow AB, et al. Diagnostic value of B-type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med 2004;116:363-368 (Pubitemid 38299480)
91. Logeart D, Saudubray C, Beyne P, Thabut G, Ennezat PV, Chavelas C, et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 2002;40:1794-1800 (Pubitemid 35341958)
92. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002;39:202-209 (Pubitemid 34084622)
93. Mueller T, Gegenhuber A, Dieplinger B. Capability of B-type natriuretic peptide (BNP) and aminoterminal proBNP as indicators of cardiac structural disease in asymptomatic patients with systemic arterial hypertension. Clin Chem 2005;51:2245-2251 (Pubitemid 41692566)
94. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-385 (Pubitemid 32147241)
95. Lim TK, Collinson PO, Celik E, Gaze D, Senior R. Value of primary care electrocardiography for the prediction of left ventricular systolic dysfunction in patients with suspected heart failure. Int J Cardiol 2007;115:73-74 (Pubitemid 44855170)
96. Goudie BM, Jarvis RI, Donnan PT, Sullivan FM, Pringle SD, Jeyaseelan S, et al. Screening for left ventricular systolic dysfunction using GP-reported ECGs. Br J Gen Pract 2007;57:191-195 (Pubitemid 46358935)
97. Cost B. Heart failure in the elderly. PhD thesis. University of Erasmus, Rotterdam; 2000.
98. Misuraca G, Serafini O, Caporale R, Battista F, Plastina F. Diagnosis of heart failure in general medicine: role of cerebral natriuretic peptide. Results of a pilot study of a population sample from Calabria. Ital Heart J 2002;3(Suppl. 9):928-932
99. Ababsa R, Jourdain P, Funck F, Deschamps P, Sadeg N. BNP and dyspnea: proposition of a diagnostic strategy based on two cut-offs. Ann Biol Clin (Paris) 2005;63:213-216 (Pubitemid 40428461)
100. Alibay Y, Beauchet A, El Mahmoud R, Schmitt C, Brun-Ney, D, Benoit MO, et al. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Biomed Pharmacother 2005;59:20-24 (Pubitemid 40312275)
101. Barcarse E, Kazanegra R, Chen A, Chiu A, Clopton P, Maisel A. Combination of B-type natriuretic peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department. Congest Heart Fail 2004;10:171-176
102. El Mahmoud R, Alibay Y, Brun-Ney D, Boulard JC, Dubourg O, Puy H, et al. Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population. Arch Mal Coeur Vans 2006;99:201-207 (Pubitemid 46211432)
103. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728-35. (Pubitemid 37000195)
104. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167 (Pubitemid 34764819)
105. Villacorta H, Duarte A, Duarte NM, Carrano A, Mesquita ET, Dohmann HJ, et al. The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Arq Bras Cardiol 2002;79:569-72, 564-568 (Pubitemid 36988879)
106. Jourdain P, Funck F, Canault E, Bellorini M, Deschamps P, Duval G, et al. Value of type B natriuretic peptide in the emergency management of patients with suspected cardiac failure. Report of 125 cases. Arch Mal Coeur Vaiss 2002;95:763-767
107. Ray P, Arthaud M, Lefort Y, Birolleau S, Beigelman C, Riou B. Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea. Intensive Care Med 2004;30:2230-2236 (Pubitemid 40174260)
108. Davis M, Espiner E, Richards G, Billings J, Town I, Neill A, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994;343:440-4. (Pubitemid 24059585)
109. Dokainish H, Zoghbi WA, Lakkis NM, Quinones MA, Nagueh SF. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. AmJ Cardiol 2004;93:1130-1135 (Pubitemid 38521042)
110. McLean AS, Tang B, Nalos M, Huang SJ, Stewart DE. Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 2003;31:21-27 (Pubitemid 36267314)
111. Nielsen LS, SvanegaardJ, Klitgaard NA, Egeblad H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail 2004;6:63-70. (Pubitemid 38169606)
112. Bayes-Genis A, Santalo-Bel M, Zapico-Muniz E, Lopez L, Cotes C, Bellido J, et al. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 2004;6:301-308 (Pubitemid 38253049)
113. Januzzi JL, Jr, Camargo CA, Anwarrudin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005;95:948-954
114. Berdague P, Caffin PY, Barazer I. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients. Am Heart J 2006;151:690-698 (Pubitemid 43290263)
115. Gadsboll N, Hoilund-Carlsen PF, Nielsen GG, Berning J, Brunn NE, Stage P, et al. Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catheterization. Eur Heart J 1989;10:1017-1028 (Pubitemid 20012833)
116. Lok CE, Morgan CD, Ranganathan N. The accuracy and interobserver agreement in detecting 'gallop sounds' by cardiac auscultation. Chest 1998;114:1283-1288
117. Barksfield R. Diagnosing heart failure in primary care. The role of clinical features and BNP: a multicentre UK diagnostic study. BSc dissertation, Imperial College London; 2005.
118. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules: a review and suggested modifications of methodological standards. JAMA 1997;277:488-494 (Pubitemid 27074334)
119. Stewart LA, Clarke MJ (on behalf of the Cochrane Working Party Group). Practical methodology of meta-analyses (overviews) using updated individual patient data. Stat Med 1995;14:2057-2079
120. Groenning BA, Raymond I, Hildebrandt PR, Nilsson JC, Baumann M, Pedersen F. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004;90:297-303. (Pubitemid 38250725)
121. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley; 2000.
122. Albert A. On the use and computation of likelihood ratios in clinical chemistry. Clin Chem 1982;28:1113-19.
123. Chan AF, Deeks JJ, Macaskill P, Irwig L. Three methods to construct predictive models using logistic regression and likelihood ratios to facilitate adjustment for pretest probability give similar results. J Clin Epidemiol 2008;61:52-63. (Pubitemid 350236696)
124. Shibata MC, Flather MD, Wang D. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 2001;3:351-357 (Pubitemid 32895844)
125. Flather MD, Yusuf S, Køber L, Pfeffer M, Hall A, Murray G, et al., for the ACE-Inhibitor Myocardial Infarction Collaborative Group. Long term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000;355:1575-1581
126. Cowie MR, Wood DA, Coats AJS, Thompson SG, Suresh V, Poole-Wilson PA, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2000;83:505-510 (Pubitemid 30316712)
127. Jong P, Demers C, McKelvie RS, Liu PP. Angiotensin receptor blockers in heart failure: meta-analysis of randomised controlled trials. J Am Coll Cardiol 2002;39:463-470 (Pubitemid 34117504)
128. Healthcare Commission. Pushing the boundaries: improving services for people with heart failure. London: Commission for Healthcare Audit and Inspection; July 2007.
129. Calvert MJ, Freemantle N, Cleland JGF. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail 2005;7:243-251 (Pubitemid 40215620)
130. Cowie MR, Fox KF, Wood DA, Metcalfe C, Thompson SG, Coats AJ, et al. Hospitalisation of patients with heart failure: a population based study. Eur Heart J 2002;23:877-885 (Pubitemid 34717423)
131. Davenport C, Cheng EYL, Kwok YTT, Lai AH, Wakabayashi T, Hyde C, et al. Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis. Br J Gen Pract 2006;56:48-56. (Pubitemid 43078217)
132. Krüger S, Filzmaier K, Graf J, Kuntz D, Stickel T, Hoffman R, et al. QRS prolongation on surface ECG and brain natriuretic peptide as indicators of left ventricular systolic dysfunction. J Intern Med 2004;255:206-212 (Pubitemid 38241364)
133. Hutcheon SD, Gillespie ND, Struthers AD, McMurdo ME. B-type natriuretic peptide in the diagnosis of cardiac disease in elderly day hospital patients. Age Ageing 2002;31:295-301.
134. Latour-Pérez J, Coves-Orts FJ, Abad-Terrado C, Abraira V, Zamora J. Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review. Eur J Heart Fail 2006;8:390-399 (Pubitemid 43842121)
135. Clerico A, Fontana M, Zyw L, Passino C, Emdin M. Comparison of the diagnostic accuracy of BNP and NTproBNP in chronic and acute heart failure: a systematic review. Clin Chem 2007;53:813-822 (Pubitemid 47342424)
136. Cardarelli R, Lumicao TG. B type natriuretic peptide: a review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians. J Am Board Fam Pract 2003;16:327-333
137. Korenstein D, Wisnivesky JP, Wyer P, Adler R, Ponieman D, McGinn T. The utility of B type natriuretic peptide in the diagnosis of heart failure in the emergency department: a systematic review. BMC Emerg Med 2007;7:6. (Pubitemid 47086725)
138. Battaglia M, Pewsner D, Juni P, Eger M, Bucher HC, Bachmann LM. Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure. Arch Intern Med 2006;166:1073-1080
139. Nielsen OW, Hansen JF, Hilden J, Larsen CT, Svanegaard J. Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests. BMJ 2000;320:220-224 (Pubitemid 30175739)
140. Sparrow N, Adlam D, Cowley A, Hampton JR. The diagnosis of heart failure in general practice: implications for the UK National Service Framework. Eur J Heart Fail 2003;5:349-354 (Pubitemid 37011865)
141. Davie AP, Francis CM, Caruana L, Sutherland GR, McMurray JJ. Assessing diagnosis in heart failure: which features are any use? QJM 1997;90:335-339
142. Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, et al. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract 2006;56:327-333
143. Gustafsson F, Steensgaard-Hansen F, Badskjaer J. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 2005;11(Suppl. 5):S15-S20.
144. Mattleman SJ, Hakki AH, Iskandrian AS, Segal BL, Kane SA. Reliability of bedside evaluation in determining left ventricular function: correlation with left ventricular ejection fraction determined by radionuclide ventriculography. J Am Coll Cardiol 1983;1(2 Pt 1):417-420
145. Rihal CS, Davis KB, Kennedy JW, Gersh BJ. The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. Am J Cardiol 1995;75:220-223
146. Wattanabe I, Tani S, Wahio T. Relationship between the plasma levels of brain natriuretic peptide and left ventricular ejection fraction in asymptomatic patients with previous myocardial infarction. Int Heart J 2005;46:1007-1014 (Pubitemid 43316745)
147. Jain AP, Gupta OP, Jajoo UN, Kumar A, Trivedi SK. Evaluation of clinical variables as predicators of left ventricular function in acute myocardial infarction. J Assoc Physicians India 1993;41:17-19.
148. Narain VS, Puri A, Gilhotra HS, Sadiq PA, Mehrotra S, Dwivedi SK, et al. Third heart sound revisited: a correlation with N-terminal pro brain natriuretic peptide and echocardiography to detect left ventricular dysfunction. Indian Heart J 2005;57:31-4. (Pubitemid 40562491)
149. Talreja D, Gruver C, Sklenar J, Dent J, Kaul S. Efficient utilization of echocardiography for the assessment of left ventricular systolic function. Am Heart J 2000;139:394-398 (Pubitemid 30149187)
150. Zema MJ, Masters AP, Margouleff D. Dyspnea: the heart or the lungs? Differentiation at bedside by use of the simple Valsalva maneuver. Chest 1984;85:59-64. (Pubitemid 14215302)
151. Ng LL, Loke I, Davies JE, Khunti K, Stone M, Abrams KR, et al. Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography. Eur J Heart Fail 2003;5:775-782 (Pubitemid 38198065)
152. Landray MJ, Lehman R, Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. BMJ 2000;320:985-986 (Pubitemid 30192872)
153. Lindsay MM, Goodfield NE, Hogg KJ, Dunn FG. Optimising direct access ECHO referral in suspected heart failure. Scott Med J 2000;45:43-44
154. Sandler DA, Steeds RP, Hadfield JW Opening access to echocardiography for general practitioners in North Derbyshire. BrJ Cardiol 2000;7:94-100.
155. Hedberg P, Lönnberg I, Jonason T, Nilsson G, Pehrsson K, Ringqvist I. Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year-old men and women. Am Heart J 2004;148:524-529 (Pubitemid 39265129)
156. Mosterd A, Deckers JW, Hoes AW, Nederpel A, Smeets A, Linker DT et al. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 1997;13:491-502. (Pubitemid 27306166)
157. Baker DW, Bahler RC, Finkelhor RS, Lauer MS. Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure. Am Heart J 2003;146:736-740 (Pubitemid 37281722)
158. Christian TF, Miller TD, Chareonthaitawee P, Hodge DO, O'Connor MK, Gibbons RJ. Prevalence of normal resting left ventricular function with normal rest electrocardiograms. Am J Cardiol 1997;79:1295-1298 (Pubitemid 27255189)
159. Houghton AR, Sparrow NJ, Toms E, Cowley AJ. Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography? Int J Cardiol 1997;62:31-36
160. Talwar S, Squire IB, Davies JE, Barnett DB, Ng LL. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur Heart J 1999;20:1736-1744
161. Gillespie ND, McNeill G, Pringle T, Ogston S, Struthers AD, Pringle SD. Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea. BMJ 1997;314:936-940 (Pubitemid 27140218)
162. Hendry A, Hacking L, Langhorne P, Vallance R, MacDonald J. Evaluation of echocardiography in the management of elderly patients with heart failure. Age Ageing 1999;28:447-450 (Pubitemid 29438514)
163. Madsen EB, Gilpin E, Slutsky RA, Ahnve S, Henning H, Ross J Jr. Usefulness of the chest x-ray for predicting abnormal left ventricular function after acute myocardial infarction. Am Heart J 1984;108:1431-1436 (Pubitemid 15075893)
164. Gadsboll N, Hoilund-Carlsen PF, Nielsen GG, Berning J, Brunn NE, Stage P, et al. Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catheterization. Eur Heart J 1989;10:1017-1028 (Pubitemid 20012833)
165. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13. (Pubitemid 28020159)
166. McGeoch G, Lainchbury J, Town GI, Toop L, Espiner E, Richards AM. Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice. Eur J Heart Fail 2002;4:479-483 (Pubitemid 36564967)
167. Smith H, Pickering RM, Struthers A, Simpson I, Mant D. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ 2000;320:906-908 (Pubitemid 30182383)
168. Sim V, Hampton D, Phillips C, Lo SN, Vasishta S, Davies J, et al. The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunction cost-effectiveness in relation to open access echocardiography. Fam Pract 2003;20:570-574 (Pubitemid 37258762)
169. Costello-Boerrigter LC, Boerrigter G, Redfield MM. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2006;47:345-353 (Pubitemid 43063253)
170. Luchner A, Burnett JC Jr, Jougasaki M, Hense HW, Heid IM, Muders F, et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 2000;18:1121-1128 (Pubitemid 30680323)
171. Lukowicz TV Fischer M, Hense HW, Doring A, Stritzke J, Riegger G, et al. BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy. Eur J Heart Fail 2005;7:525-531 (Pubitemid 40732982)
172. Vasan RS, Benjamin FJ, Larson MG, Leip EP, Wang TJ, Wilson PW, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 2002;288:1252-1259 (Pubitemid 35001328)
173. Atisha D, Bhalla MA, Morrison LK, Felicio L, Clopton P, Gardetto N, et al. A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction. Am Heart J 2004;148:518-523 (Pubitemid 39265128)
174. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study. Am J Med 2004;116:509-516 (Pubitemid 38452641)
175. Falkensammer G, Lechleitner P, Hammerer-Lercher A, Theurl A, Puschendorf B, Mair J. B-type natriuretic peptide and N-terminal pro brain natriuretic peptide are related to systolic and diastolic left ventricular function assessed by radionuclide ventriculography. Int J Cardiol 2005;105:340-341 (Pubitemid 41605089)
176. Krishnaswamy P, Lubien E, Clopton P, Koon J, Kazanegra R, Wanner E, et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001;111:274-279 (Pubitemid 32885622)
177. Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 2001;59:1559-1566 (Pubitemid 32281248)
178. Richards M, Nicholls MG, Espiner EA. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 2006;47:52-60. (Pubitemid 43005164)
179. Valli N, Georges A, Corcuff JB, Barat JL, Bordenave L. Assessment of brain natriuretic peptide in patients with suspected heart failure: comparison with radionuclide ventriculography data. Clin Chim Acta 2001;306:19-26. (Pubitemid 32244321)
180. Vanderheyden M, Bartunek, Claeys G. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction. Clin Biochem 2006;39:640-645 (Pubitemid 44192393)
181. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94. (Pubitemid 26415815)
182. Yamamoto K, Burnett JC Jr, Bermudez EA, Jougasaki M, Bailey KR, Redfield MM. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail 2000;6:194-200. (Pubitemid 30683545)
183. Bal L, Thierry S, Brocas E. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress. Acta Anaesthesiol Scand 2006;50:340-347
184. Bettencourt P, Ferreira A, Pardal-Oliveira N, Pereira M, Queiros C, Araujo V, et al. Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction. Clin Cardiol 2000;23:921-7.
185. Byrne J, Morton JJ, Metcalfe MJ, Dargie HJ. Brain natriuretic peptide (BNP) and simple clinical variables predict left ventricular dysfunction following myocardial infarction. Heart 1996;75(Suppl. 1):531.
186. Choy AM, Darbar D, Lang CC, Pringle TH, McNeill GP, Kennedy NS, et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J 1994;72:16-22. (Pubitemid 24245380)
187. Osca J, Quesada A, Arnau MA, Osa A, Hervas I, Almenar L, et al. [Brain natriuretic peptide. Diagnostic value in heart failure]. Rev Esp Cardiol 2002;55:7-15.
188. Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. [The value of natriuretic peptides NT-pro-BNP and BNP for the assessment of left-ventricular volume and function. A prospective study of 150 patients]. Dtsch Med Wochenschr 2002;127:2605-2609
189. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-1929 (Pubitemid 28222186)
190. Groenning BA, Raymond I, Hildebrandt PR, Nilsson JC, Baumann M, Pedersen F. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004;90:297-303. (Pubitemid 38250725)
191. Sivakumar R, Wellsted D, Parker K. Utility of N terminal pro brain natriuretic peptide in elderly patients. Postgrad Med J 2006;82:220-223
192. Thackray SD, Witte K, Ghosh J. N-terminal brain natriuretic peptide as a screening tool for heart failure in the pacemaker population. Eur Heart J 2006;27:447-453 (Pubitemid 43209170)
193. Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 2003;89:150-154 (Pubitemid 36115095)
194. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP). Clin Chem Lab Med 2004;42:159-163 (Pubitemid 38401442)
195. McNamara RF, Carleen E, Moss AJ. Estimating left ventricular ejection fraction after myocardial infarction by various clinical parameters. Am J Cardiol 1988;62:192-196 (Pubitemid 18183457)
196. Khandekar S, Murphy JJ, Bossingham CM. Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction. Echocardiography is still necessary. BMJ 1996;312:1160.
197. Luchner A, Hengstenberg C, Lowel H, Trawinski J, Baumann M, et al. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 2002;39:99-104. (Pubitemid 34098096)